Elliott Statement on Telecom Italia
Elliott Advisors (UK) Limited (“Elliott”) welcomes Vivendi’s decision to withdraw its request to shareholders to revoke five of Telecom Italia’s (“TIM”) Directors, a clear sign that Vivendi understands that there is broad support for TIM’s existing independent Board. This outcome is a victory for the Company and paves the way for stability and sustained value creation for all of TIM’s stakeholders. Elliott remains fully supportive of CEO Luigi Gubitosi, the Company’s management team and the existing independent Board, and looks forward to constructive dialogue with all stakeholders to pursue a value maximising path forward for the Company.
Elliott Management Corporation manages two multi-strategy funds which combined have approximately $34 billion of assets under management. Its flagship fund, Elliott Associates, L.P., was founded in 1977, making it one of the oldest funds of its kind under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Management Corporation.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
THE-SMARTER-E-EUROPE25.4.2019 11:55:09 CEST | Pressemeddelelse
The Smarter E Europe – Explore Sector Coupling for Yourself at Europe’s Largest Platform for the Energy Industry
MA-EVALUATE25.4.2019 09:02:05 CEST | Pressemeddelelse
The “One and Done” Era for Orphan Drugs: Evaluate Predicts 12% Growth, Driven by New Technologies, but Benefits Go to Big Pharma
NTT-COMMUNICATIONS25.4.2019 08:02:05 CEST | Pressemeddelelse
NTT Group Increases Capital in NTT Global Data Centers Corp. to Further Strengthen Data Center Business
CHINA-YIWU-FAIR25.4.2019 07:51:05 CEST | Pressemeddelelse
China Yiwu Imported Commodities Fair 2019 to Open in May
MA-NEC/BOSTONGENE25.4.2019 03:02:05 CEST | Pressemeddelelse
Biomedical Software Startup BostonGene Secures $50M in Series A Financing from NEC
PA-KNOPP-BIOSCIENCES24.4.2019 20:52:04 CEST | Pressemeddelelse
Knopp Biosciences Receives FDA Orphan Drug Designation for Dexpramipexole for Treatment of Hypereosinophilic Syndrome
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum